BIO protocol complete project overview

Muhammad Arbaz
0

 BIO protocol complete project overview


BIO protocol complete project overview. Bio Protocol (BIO) is a cutting edge platform which is transforming the field of scientific research and biotechnology funding through the use of blockchain technology. Founded in early January 2025, BIO is in the race to compete with the recent players in the decentralized science sector. 

BIO protocol complete project overview


Project Description


Bio Protocol identifies shortcomings of the traditional schemes of science organization such as the long winded process involved in applying for funds, the unequal regional access to funds, and even the commercialization of IP. It utilizes decentralized technology to connect patients, scientists, and investors from different parts of the world who can now help fund and own tokenized biotech and IP projects. 


Some of the main pillars of Bio Protocol are:


Direct Investment: Individuals are encouraged to directly invest in biotech projects. 


Diverse Workforce: Provides access to researchers and investors around the world.


Fractional Ownership: Tokenized scientific IP is shared 


Early Cash Liquidity: Investments that have been usually hard to sell are now liquid.

Token Launch and Market Activities


The BIO token was officially listed on the leading cryptocurrency exchanges, Binance included, on 3nd January 2025. The token was initially offered at $ 1.40 however it was highly speculative and experienced considerable fluctuations, reaching a high of $1.477 and currently trading around $0.70.


The token distribution is as follows:


Total Supply: Three point three two billion BIO tokens.


Initial Circulating Supply: Close to 39% (1.296 billion tokens) at the time of listing.


Community Allocations:


Community Airdrop: Six percent (199.2 million BIO)


Community Auction: Twenty percent (664 million BIO)


Ecosystem Incentives: Twenty percent (830 million BIO)


Molecule Ecosystem Fund: Five percent (166 million BIO)




Other Allocations:


Core Contributors – 21.2 % (703.84 million BIO) 


Investors – 13.6 % (451.52 million BIO) 


Molecule- 5% (166 million BIO) 


Advisors – 4.2 % (139.44 million BIO) 



Ecosystem and Future Plans


Bio Protocol operates as an incubator for a variety of BioDAOs, decentralized autonomous organizations that are owned by the communities and are focused on one specific biotechnology. BioDAOs supplement IP projects by working together to develop and research technologies through funding from the commercialization of their IP.

At present, Bio Protocol includes eight distinct sub-DAOs, each of which is concerned with specific areas of interest such as basement hormones and libido, learning and memory, hair loss, women’s health, long covid, and uncommon diseases. Certainly, one of the most popular sub-DAOs in the ecosystem is VitaDAO, which specializes in longevity science.


Looking ahead, Bio Protocol is anticipated to:


Integrate More Chains: Incorporate other chains such as solana for enhanced liquidity and wider applicability across chains.


Bring Forth DeSci AI Agents: Roll out AI agents that can further promote decentralized scientific research.


Create Additional BioDAOs: Create more BioDAOs that could research and invest in younger biotechnologies.


Shift Governance Mechanisms: Administer strategic structures in different blockchains to allow for decentralized decision making.



Conclusion


The Bio Protocol is a major step forward for the DeSci community in its desire for more democratization and decentralization of the funding and development of scientists’ work. It seeks to refine the world of science by using blockchain technology alongside biotechnology in order to build a faster, fairer, and more transparent ecosystem.

How to Make a Gmail Account

Unlocking Your Potential A Comprehensive Guide to Launching Your YouTube Channel

How to Earn Money with Hylink.me: A Comprehensive Guide

5G AND 6G Networks The Future of Connectivity and What It Means for You

Post a Comment

0Comments

Post a Comment (0)